Trials / Completed
CompletedNCT02417935
A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP)
A Japan Post-Marketing, Randomized, Double-Blind, Parallel-Group, Flexible Dose Comparative Study to Assess the Non-Inferiority of Duloxetine Compared With Pregabalin in Patients With Diabetic Peripheral Neuropathic Pain
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 304 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 20 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to evaluate the effectiveness and safety of the study drug known as duloxetine in participants with diabetic peripheral neuropathic pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine | Administered orally |
| DRUG | Pregabalin | Administered orally |
| DRUG | Placebo | Administered orally |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2017-05-13
- Completion
- 2017-05-13
- First posted
- 2015-04-16
- Last updated
- 2019-09-18
- Results posted
- 2018-07-10
Source: ClinicalTrials.gov record NCT02417935. Inclusion in this directory is not an endorsement.